Host: Jennifer Caudle, DO     Guest: Roy Rosin, MBA     Guest: Shivan Mehta, MD, MBA, MSHP  From home care to cancer screening, what are some of the top initiatives in patient care at Penn Medicine’s new Acceleration Lab? Mr. Roy Rosin and Dr. Shivan Mehta sit down with Dr. Jennifer Caudle to share the latest updates from the Acceleration Lab.

Host: Jennifer Caudle, DO Guest: Roy Rosin, MBA Guest: Shivan Mehta, MD, MBA, MSHP From home care to cancer screening, what are some of the top initiatives in patient care at Penn Medicine’s new Acceleration Lab? Mr. Roy Rosin and Dr. Shivan Mehta sit down with Dr. Jennifer Caudle to share the latest updates from the Acceleration Lab.

The Acceleration Lab: Key Initiatives in Patient-Centered Care


Host: Charles Turck, PharmD, BCPS, BCCCP     Guest: Elise Chong, MD  Patients with follicular lymphoma who relapse or don’t respond to treatment don’t have many therapeutic options, but a recently FDA-approved CAR T-cell therapy may help change that. Dr. Charles Turck is joined by Dr. Elise Chong from Penn Medicine’s Abramson Cancer Center to explore this new treatment option.

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Elise Chong, MD Patients with follicular lymphoma who relapse or don’t respond to treatment don’t have many therapeutic options, but a recently FDA-approved CAR T-cell therapy may help change that. Dr. Charles Turck is joined by Dr. Elise Chong from Penn Medicine’s Abramson Cancer Center to explore this new treatment option.

Considering CAR T-cell Therapy in Follicular Lymphoma


Host: Charles Turck, PharmD, BCPS, BCCCP     Guest: Kirstin Leitner, MD  Current screening tools for postpartum depression may have limitations, but a new texting service as part of the Healing at Home program may help clinicians detect postpartum depression earlier. Dr. Charles Turck is joined by Dr. Kirstin Leitner to take a look at this program and its impacts.

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Kirstin Leitner, MD Current screening tools for postpartum depression may have limitations, but a new texting service as part of the Healing at Home program may help clinicians detect postpartum depression earlier. Dr. Charles Turck is joined by Dr. Kirstin Leitner to take a look at this program and its impacts.

Healing at Home: Advancements in Screening for Postpartum Depression


Host: Charles Turck, PharmD, BCPS, BCCCP     Guest: Kathryn Gallagher, MS, RN, BSN     Guest: Kate Newcomb-DeSanto, MSN, RN, MSW  What does Penn Medicine’s newly-opened patient room facility have to offer? Dr. Charles Turck is joined by Penn Medicine Clinical Advisors Kathy Gallagher and Kate Newcomb-DeSanto to discuss the new pavilion and how it's revolutionizing patient care. 

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Kathryn Gallagher, MS, RN, BSN Guest: Kate Newcomb-DeSanto, MSN, RN, MSW What does Penn Medicine’s newly-opened patient room facility have to offer? Dr. Charles Turck is joined by Penn Medicine Clinical Advisors Kathy Gallagher and Kate Newcomb-DeSanto to discuss the new pavilion and how it's revolutionizing patient care.

A Peek Inside the Pavilion: Exploring Penn Medicine’s Newest Facility


Host: Charles Turck, PharmD, BCPS, BCCCP     Guest: Drew Weissman, MD, PhD  Dr. Drew Weissman, Professor of Medicine at Penn Medicine joins Dr. Turck to discuss his new COVID-19 vaccine technology and how RNA and mRNA are being used to provoke an immune response in order to combat the COVID-19 pandemic.

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Drew Weissman, MD, PhD Dr. Drew Weissman, Professor of Medicine at Penn Medicine joins Dr. Turck to discuss his new COVID-19 vaccine technology and how RNA and mRNA are being used to provoke an immune response in order to combat the COVID-19 pandemic.

Exploring the Benefits & Safety of COVID-19 Vaccine Technology


Host: Jennifer Caudle, DO     Guest: Kathleen E. O'Neill, MD, MTR     Guest: Nawar Abdul Latif, MD, MPH, MSCE  Patients with uterine factor infertility, or UFI, only had two options if they wanted to achieve parenthood: using a gestational carrier or adoption. Until now. Joining Dr. Jennifer Caudle to talk about the opportunities of uterine transplants and key information about the UNTIL trial are lead investigators Drs. Kathleen O’Neill and Nawar Latif from Penn Medicine.

Host: Jennifer Caudle, DO Guest: Kathleen E. O'Neill, MD, MTR Guest: Nawar Abdul Latif, MD, MPH, MSCE Patients with uterine factor infertility, or UFI, only had two options if they wanted to achieve parenthood: using a gestational carrier or adoption. Until now. Joining Dr. Jennifer Caudle to talk about the opportunities of uterine transplants and key information about the UNTIL trial are lead investigators Drs. Kathleen O’Neill and Nawar Latif from Penn Medicine.

Updates in Uterine Factor Infertility: The Promise of Transplants


Host: Jennifer Caudle, DO     Guest: Amit Bar-Or, MD, FRCP, FAAN, FANA  Joining Dr. Jennifer Caudle to discuss the latest research furthering our understanding and treatment of multiple sclerosis is Dr. Amit Bar-Or, Chief of the Multiple Sclerosis Division and Director for the Center of Neuroinflammation and Neurotherapeutics at Penn Medicine. Could these recent findings finally help us solve some of the unanswered questions of multiple sclerosis?

Host: Jennifer Caudle, DO Guest: Amit Bar-Or, MD, FRCP, FAAN, FANA Joining Dr. Jennifer Caudle to discuss the latest research furthering our understanding and treatment of multiple sclerosis is Dr. Amit Bar-Or, Chief of the Multiple Sclerosis Division and Director for the Center of Neuroinflammation and Neurotherapeutics at Penn Medicine. Could these recent findings finally help us solve some of the unanswered questions of multiple sclerosis?

Expanding Options for the Management of Multiple Sclerosis


Host: Jennifer Caudle, DO     Guest: Anjali Owens, MD  Without any targeted therapies available for inherited cardiomyopathy, how can we treat our patients coping with its debilitating symptoms? Here to share her diagnostic and management strategies along with key data from a recent study is Dr. Anjali Owens, Medical Director at the Center for Inherited Heart Disease at Penn Medicine.

Host: Jennifer Caudle, DO Guest: Anjali Owens, MD Without any targeted therapies available for inherited cardiomyopathy, how can we treat our patients coping with its debilitating symptoms? Here to share her diagnostic and management strategies along with key data from a recent study is Dr. Anjali Owens, Medical Director at the Center for Inherited Heart Disease at Penn Medicine.

Gaining a Deeper Understanding of Inherited Cardiomyopathy


Host: Matt Birnholz, MD     Guest: Howard C. Herrmann, MD  Twelve years after performing the first transcatheter aortic valve replacement, Penn Medicine continues to gain momentum in the transformation of cardiovascular transcatheter therapies. Dr. Howard Herrmann recounts the evolution in alternative technologies to improve patient safety and outcomes and the role these advancements have in shaping how we approach treatment.

Host: Matt Birnholz, MD Guest: Howard C. Herrmann, MD Twelve years after performing the first transcatheter aortic valve replacement, Penn Medicine continues to gain momentum in the transformation of cardiovascular transcatheter therapies. Dr. Howard Herrmann recounts the evolution in alternative technologies to improve patient safety and outcomes and the role these advancements have in shaping how we approach treatment.

Endeavors of the Heart: Leveraging Innovative Technologies for Transcatheter Therapies


Host: Jennifer Caudle, DO     Guest: Suhail K. Kanchwala, MD  Improving his patients’ post-surgical experience was Dr. Suhail Kanchwala's goal when he sought to develop a new method for autologous breast reconstruction. The result of his search has brought a new technique to the field, along with an array of benefits for patients, including reduction of post-surgical pain and opioid use.

Host: Jennifer Caudle, DO Guest: Suhail K. Kanchwala, MD Improving his patients’ post-surgical experience was Dr. Suhail Kanchwala's goal when he sought to develop a new method for autologous breast reconstruction. The result of his search has brought a new technique to the field, along with an array of benefits for patients, including reduction of post-surgical pain and opioid use.

Reinventing Autologous Breast Reconstruction to Reduce Pain & Postsurgical Opioid Use


Medical Breakthroughs features the newest medical advancements in the areas of oncology, cardiology, neurosciences, orthopedics, and genetics featuring America’s leading physicians and medical researchers from Penn Medicine.

Medical Breakthroughs from Penn Medicine

Host: Shira Johnson, MD     Guest: Robert Vonderheide, MD  For years, the foundations of cancer treatment, surgery, chemotherapy, and radiation therapy were utilized with the objective of weakening cancer. But over the past several years, immunotherapy – therapies that enlist and strengthen the power of a patient’s immune system to attack tumors - has emerged as a new tool for fighting cancer. In August 2017, one such treatment approach, called Chimeric Antigen Receptor or CAR T-cell Therapy, received FDA approval for the treatment of children and young adults with acute lymphoblastic leukemia (ALL). Additionally, research is continuing to look at CAR-T therapy’s effectiveness for treating solid tumors as well. Host Dr. Shira Johnson sits down with Dr. Robert Vonderheide, Director of the Abramson Cancer Center of the University of Pennsylvania and the John H. Glick, MD, Abramson Cancer Center Director’s Professor, to talk about the potential of CAR-T therapy alongside other emerging immunotherapies in fighting cancer.

Host: Shira Johnson, MD Guest: Robert Vonderheide, MD For years, the foundations of cancer treatment, surgery, chemotherapy, and radiation therapy were utilized with the objective of weakening cancer. But over the past several years, immunotherapy – therapies that enlist and strengthen the power of a patient’s immune system to attack tumors - has emerged as a new tool for fighting cancer. In August 2017, one such treatment approach, called Chimeric Antigen Receptor or CAR T-cell Therapy, received FDA approval for the treatment of children and young adults with acute lymphoblastic leukemia (ALL). Additionally, research is continuing to look at CAR-T therapy’s effectiveness for treating solid tumors as well. Host Dr. Shira Johnson sits down with Dr. Robert Vonderheide, Director of the Abramson Cancer Center of the University of Pennsylvania and the John H. Glick, MD, Abramson Cancer Center Director’s Professor, to talk about the potential of CAR-T therapy alongside other emerging immunotherapies in fighting cancer.

CAR-T Cell Therapy: A Breakthrough Treatment for Fighting Cancer


Host: Lee Freedman, MD  How does surgery and stenting for carotid lesions help prevent stroke? What are the latest approaches, clinical trials, and philosophy for dialysis access for patients? Host Dr. Lee Freedman welcomes Dr. Benjamin Jackson to answer these questions and the latest innovations in vascular surgery at the University of Pennsylvania Hospital. Dr. Jackson is an Assistant Professor of Surgery in Radiology at the University of Pennsylvania Hospital.

Host: Lee Freedman, MD How does surgery and stenting for carotid lesions help prevent stroke? What are the latest approaches, clinical trials, and philosophy for dialysis access for patients? Host Dr. Lee Freedman welcomes Dr. Benjamin Jackson to answer these questions and the latest innovations in vascular surgery at the University of Pennsylvania Hospital. Dr. Jackson is an Assistant Professor of Surgery in Radiology at the University of Pennsylvania Hospital.

Innovations in Vascular Surgery


Host: Frank Russomano  There are far too many diseases that do not have proven means of prevention or effective treatments. As such, health care providers must gain better insights into the biology of these diseases to make a difference for the millions of patients who suffer from them. Precision medicine is an emerging approach for treatment and prevention that accounts for individual variability in genes, environment, and lifestyle. Host Frank Russomano welcomes Brian Wells, Associate Vice President of Health Technology and Academic Computing at Penn Medicine, to discuss how Penn Medicine contributes to the precision medicine initiative, from technological developments to supportive infrastructures.

Host: Frank Russomano There are far too many diseases that do not have proven means of prevention or effective treatments. As such, health care providers must gain better insights into the biology of these diseases to make a difference for the millions of patients who suffer from them. Precision medicine is an emerging approach for treatment and prevention that accounts for individual variability in genes, environment, and lifestyle. Host Frank Russomano welcomes Brian Wells, Associate Vice President of Health Technology and Academic Computing at Penn Medicine, to discuss how Penn Medicine contributes to the precision medicine initiative, from technological developments to supportive infrastructures.

The Role of Technology in Precision Medicine


Host: Lee Freedman, MD     Guest: Craig Israelite, MD  Dr. Craig Israelite, assistant professor of orthopedic surgery at the University of Pennsylvania School of Medicine, discusses a series of approaches to knee osteoarthritis. A brief review of non-surgical treatment is followed by a discussion of image-guided surgery, minimally invasive surgery, partial knee replacements and the post-operative use of multi-modal pain strategies. Dr. Lee Freedman hosts.

Host: Lee Freedman, MD Guest: Craig Israelite, MD Dr. Craig Israelite, assistant professor of orthopedic surgery at the University of Pennsylvania School of Medicine, discusses a series of approaches to knee osteoarthritis. A brief review of non-surgical treatment is followed by a discussion of image-guided surgery, minimally invasive surgery, partial knee replacements and the post-operative use of multi-modal pain strategies. Dr. Lee Freedman hosts.<a href="https://md.sermo.com/medical/article/news?pid=4282" rel="nofollow" target="_blank"> </a>

Surgical Advances in Knee Osteoarthritis


Guest: Louis Soslowsky, PhD     Host: Lee Freedman, MD           Dr. Louis Soslowsky, from the University of Pennsylvania Health System, outlines how newer understanding of the mechanism of injury in overuse syndromes is leading to new approaches in treatment. Dr. Soslowsky shares his expertise in biomedical engineering to help doctors fine tune their approach to rotator cuff tendinosis, epicondylitis and other common clinical problems caused by overused tendons.

Guest: Louis Soslowsky, PhD Host: Lee Freedman, MD Dr. Louis Soslowsky, from the University of Pennsylvania Health System, outlines how newer understanding of the mechanism of injury in overuse syndromes is leading to new approaches in treatment. Dr. Soslowsky shares his expertise in biomedical engineering to help doctors fine tune their approach to rotator cuff tendinosis, epicondylitis and other common clinical problems caused by overused tendons.

Overuse Tendon Injuries:  New Approaches


Host: Jennifer Caudle, DO     Guest: Joseph Berger, MD, FACP, FAAN, FANA  Multiple sclerosis is a notoriously difficult disease to diagnose early on. With no singular confirmatory tests yet available, physicians often become reluctant to identify MS in their patients, leading to years of diagnostic and treatment uncertainty. But new innovations are helping doctors establish earlier diagnoses and start more targeted treatments for MS patients.  Dr. Jennifer Caudle welcomes Dr. Joseph Berger, Professor of Neurology at Penn Medicine, to explore some of these innovations advancing MS diagnosis and treatment.

Host: Jennifer Caudle, DO Guest: Joseph Berger, MD, FACP, FAAN, FANA Multiple sclerosis is a notoriously difficult disease to diagnose early on. With no singular confirmatory tests yet available, physicians often become reluctant to identify MS in their patients, leading to years of diagnostic and treatment uncertainty. But new innovations are helping doctors establish earlier diagnoses and start more targeted treatments for MS patients. Dr. Jennifer Caudle welcomes Dr. Joseph Berger, Professor of Neurology at Penn Medicine, to explore some of these innovations advancing MS diagnosis and treatment.

Innovations in Diagnosis and Treatment of Multiple Sclerosis


Host: Jennifer Caudle, DO     Guest: Kathryn Davis, MD, MTR     Guest: Timothy Lucas, MD, PhD  According to the epilepsy foundation, epilepsy is the 4th most common neurological problem in the U.S. – only migraine, stroke and Alzheimer’s disease occur more frequently. The average incidence of epilepsy each year in the U. S is estimated at 150,000, or 48 for every 100,000 people. Host Dr. Jennifer Caudle talks with Doctors Kathryn Davis and Timothy Lucas about advances in treatment for epilepsy at Penn Medicine. Dr. Davis is Assistant Professor of Neurology and Medical Director of the Epilepsy Monitoring Unit and Epilepsy Surgical Program. Dr. Timothy Lucas is Assistant Professor of Neurosurgery, Surgical Director at the Penn Epilepsy Center, and Director of the Penn Center for Laser Neurosurgery.

Host: Jennifer Caudle, DO Guest: Kathryn Davis, MD, MTR Guest: Timothy Lucas, MD, PhD According to the epilepsy foundation, epilepsy is the 4th most common neurological problem in the U.S. – only migraine, stroke and Alzheimer’s disease occur more frequently. The average incidence of epilepsy each year in the U. S is estimated at 150,000, or 48 for every 100,000 people. Host Dr. Jennifer Caudle talks with Doctors Kathryn Davis and Timothy Lucas about advances in treatment for epilepsy at Penn Medicine. Dr. Davis is Assistant Professor of Neurology and Medical Director of the Epilepsy Monitoring Unit and Epilepsy Surgical Program. Dr. Timothy Lucas is Assistant Professor of Neurosurgery, Surgical Director at the Penn Epilepsy Center, and Director of the Penn Center for Laser Neurosurgery.

4 Latest Advances in Epilepsy Treatment at Penn


Host: Lee Freedman, MD  Heated/Hyperthermic Intraperitoneal Chemotherapy (HIPEC) is one of the most innovative treatments available today for complex abdominal cancers. What is it? Who is a candidate? And, what are the expected outcomes for our patients? Host Dr. Lee Freedman welcomes Dr. Giorgos Karakousis, Assistant Professor of Surgery at the Hospital of the University of Pennsylvania to discuss HIPEC.

Host: Lee Freedman, MD Heated/Hyperthermic Intraperitoneal Chemotherapy (HIPEC) is one of the most innovative treatments available today for complex abdominal cancers. What is it? Who is a candidate? And, what are the expected outcomes for our patients? Host Dr. Lee Freedman welcomes Dr. Giorgos Karakousis, Assistant Professor of Surgery at the Hospital of the University of Pennsylvania to discuss HIPEC.

Heated Intraperitoneal Chemotherapy (HIPEC) for Advanced Abdominal Cancers


Host: Jennifer Caudle, DO     Guest: Jean Bennett, MD, PhD     Guest: Albert Maguire, MD  Power couple Drs. Jean Bennett and Albert Maguire discuss how their new therapy for the RPE65 gene, which causes retinal blindness, was recently approved by the FDA to become the first gene therapy treatment for a genetic disease in the United States and the first worldwide treatment for inherited blindness. Not only do they delve into the mechanics of the corrected gene injection, but they also explain what this milestone means for patient eligibility and how their marriage has played a role in the success of their research partnership. Dr. Jean Bennett is the F.M. Kirby Professor of Ophthalmology at the Perelman School of Medicine at the University of Pennsylvania, and Dr. Albert Maguire is a Professor of Ophthalmology at the Hospital of the University of Pennsylvania and Attending Physician in the Division of Pediatric Ophthalmology at Children’s Hospital of Philadelphia.

Host: Jennifer Caudle, DO Guest: Jean Bennett, MD, PhD Guest: Albert Maguire, MD Power couple Drs. Jean Bennett and Albert Maguire discuss how their new therapy for the RPE65 gene, which causes retinal blindness, was recently approved by the FDA to become the first gene therapy treatment for a genetic disease in the United States and the first worldwide treatment for inherited blindness. Not only do they delve into the mechanics of the corrected gene injection, but they also explain what this milestone means for patient eligibility and how their marriage has played a role in the success of their research partnership. Dr. Jean Bennett is the F.M. Kirby Professor of Ophthalmology at the Perelman School of Medicine at the University of Pennsylvania, and Dr. Albert Maguire is a Professor of Ophthalmology at the Hospital of the University of Pennsylvania and Attending Physician in the Division of Pediatric Ophthalmology at Children’s Hospital of Philadelphia.

FDA-Approved Gene Therapy Reverses Blindness in Children & Adults


Guest: William Welch, MD     Host: Lee Freedman, MD  Advancing surgical treatments and devices are producing better outcomes for patients with spinal problems. How do these innovations alleviate pain associated with spinal stenosis, spinal metastases and spine trauma? Dr. William Welch, chief of neurosurgery at Pennsylvania Hospital, describes new spinal implants, including the X-STOP device, and motion preservation systems that are replacing traditional fusions.

Guest: William Welch, MD Host: Lee Freedman, MD Advancing surgical treatments and devices are producing better outcomes for patients with spinal problems. How do these innovations alleviate pain associated with spinal stenosis, spinal metastases and spine trauma? Dr. William Welch, chief of neurosurgery at Pennsylvania Hospital, describes new spinal implants, including the X-STOP device, and motion preservation systems that are replacing traditional fusions.

New Surgical Options for Spinal Disorders


Host: Lee Freedman, MD     Guest: Craig Israelite, MD  Dr. Israelite intially reviews some basic concepts in the approach to osteoarthritis. He then outlines recent surgical advances in the treatment of osteoarthritis of the hip that have led to better outcomes for our patients. These include minimally invasive surgery, progress in postoperative rehabilitation and the development of new bearing surfaces that both improve range of motion and extend the life of the hip prosthesis.

Host: Lee Freedman, MD Guest: Craig Israelite, MD Dr. Israelite intially reviews some basic concepts in the approach to osteoarthritis. He then outlines recent surgical advances in the treatment of osteoarthritis of the hip that have led to better outcomes for our patients. These include minimally invasive surgery, progress in postoperative rehabilitation and the development of new bearing surfaces that both improve range of motion and extend the life of the hip prosthesis.

Surgical Breakthroughs In Hip Osteoarthritis


Host: Lee Freedman, MD     Guest: Emile Mohler III, MD  How should we approach vulnerable plaques in the coronaries and how can we calculate more precise risk levels in both high- and average-risk patients? Host Dr. Lee Freedman addresses diagnosis and treatment options with Dr. Emile Mohler III, associate professor of medicine and director of vascular medicine within the University of Pennsylvania Health System. Dr. Mohler passed away in October 2017. This interview honors his commitment and dedication to medicine.

Host: Lee Freedman, MD Guest: Emile Mohler III, MD How should we approach vulnerable plaques in the coronaries and how can we calculate more precise risk levels in both high- and average-risk patients? Host Dr. Lee Freedman addresses diagnosis and treatment options with Dr. Emile Mohler III, associate professor of medicine and director of vascular medicine within the University of Pennsylvania Health System. Dr. Mohler passed away in October 2017. This interview honors his commitment and dedication to medicine.

Approaching Vulnerable Plaque in the Coronaries


Host: Lee Freedman, MD     Guest: Emile Mohler III, MD  A ruptured vascular plaque with subsequent thrombus often triggers the heart attack that occurs without warning. How do we identify and treat at-risk cardiac patients? Host Dr. Lee Freedman discusses an array of tools to evaluate plaque burden and promote plaque stabilization with Dr. Emile Mohler III, associate professor of medicine and director of vascular medicine within the University of Pennsylvania Health System.  Dr. Mohler passed away in October 2017. This interview honors his commitment and dedication to medicine.

Host: Lee Freedman, MD Guest: Emile Mohler III, MD A ruptured vascular plaque with subsequent thrombus often triggers the heart attack that occurs without warning. How do we identify and treat at-risk cardiac patients? Host Dr. Lee Freedman discusses an array of tools to evaluate plaque burden and promote plaque stabilization with Dr. Emile Mohler III, associate professor of medicine and director of vascular medicine within the University of Pennsylvania Health System. <a href="https://md.sermo.com/medical/article/news?pid=4282" rel="nofollow" target="_blank"> </a> Dr. Mohler passed away in October 2017. This interview honors his commitment and dedication to medicine.

Addressing Vascular Plaque Ruptures


Host: Shira Johnson, MD  For the first time, Penn Medicine surgeons were able to complete a bilateral hand transplant on a child. The surgical team successfully transplanted donor hands and forearms onto 8-year-old Zion Harvey who, several years earlier, had undergone amputation of his hands and feet and a kidney transplant following a serious infection. Host Dr. Shira Johnson sits down with Dr. Scott Levin, who led the surgical team and is Chairman of the Department of Orthopaedic Surgery at Penn Medicine. They discuss this remarkable, groundbreaking surgery.

Host: Shira Johnson, MD For the first time, Penn Medicine surgeons were able to complete a bilateral hand transplant on a child. The surgical team successfully transplanted donor hands and forearms onto 8-year-old <a href="http://www.chop.edu/stories/zion-s-story-gift-hands" rel="nofollow" target="_blank">Zion Harvey</a> who, several years earlier, had undergone amputation of his hands and feet and a kidney transplant following a serious infection. Host Dr. Shira Johnson sits down with Dr. Scott Levin, who led the surgical team and is Chairman of the Department of Orthopaedic Surgery at Penn Medicine. They discuss this remarkable, groundbreaking surgery.

Groundbreaking Child Bilateral Hand Transplant


Host: Barnett Mennen, MD     Guest: Comron Saifi, MD  Spinal deformity places strain on the vertebrae and supporting muscles, tendons, ligaments, and tissues supporting the spinal column. The treatment and management of this condition becomes centrally important to maintain patient quality of life through functional mobility and activity levels. Host, Dr. Barry Mennen and Dr. Comron Saifi discuss the leading assessment and treatment options for spinal deformity. Dr. Saifi is an Assistant Professor of Orthopaedic Surgery in the Division of Spine Surgery at the Perelman School of Medicine at the University of Pennsylvania.

Host: Barnett Mennen, MD Guest: Comron Saifi, MD Spinal deformity places strain on the vertebrae and supporting muscles, tendons, ligaments, and tissues supporting the spinal column. The treatment and management of this condition becomes centrally important to maintain patient quality of life through functional mobility and activity levels. Host, Dr. Barry Mennen and Dr. Comron Saifi discuss the leading assessment and treatment options for spinal deformity. Dr. Saifi is an Assistant Professor of Orthopaedic Surgery in the Division of Spine Surgery at the Perelman School of Medicine at the University of Pennsylvania.

When Your Patient Has a Spinal Deformity: Clinical Priorities


Host: Shira Johnson, MD     Guest: Ronald DeMatteo, MD, FACS  A Gastrointestinal Stromal Tumor (GIST) is a rare sarcoma that begins in the digestive tract or stomach, with an incident rate in the United States of approximately 4,000 to 6,000 cases per year. Since these tumors behave differently from other gastrointestinal cancers, they require a specialized treatment plan. Host Dr. Shira Johnson chats with Ronald DeMatteo, MD, FACS, Chair of the Department of Surgery and a surgical oncologist at Penn Medicine. They discuss the diagnosis, treatment and current clinical research of GIST. Dr. DeMatteo is a world-renowned surgical expert and researcher for the rare GIST. His research breakthroughs helped develop the new standard of care for GIST.

Host: Shira Johnson, MD Guest: Ronald DeMatteo, MD, FACS A Gastrointestinal Stromal Tumor (GIST) is a rare sarcoma that begins in the digestive tract or stomach, with an incident rate in the United States of approximately 4,000 to 6,000 cases per year. Since these tumors behave differently from other gastrointestinal cancers, they require a specialized treatment plan. Host Dr. Shira Johnson chats with Ronald DeMatteo, MD, FACS, Chair of the Department of Surgery and a surgical oncologist at Penn Medicine. They discuss the diagnosis, treatment and current clinical research of GIST. Dr. DeMatteo is a world-renowned surgical expert and researcher for the rare GIST. His research breakthroughs helped develop the new standard of care for GIST.

What to Know About a State-of-the-Art Approach to GIST Treatment


The best podcasts about ourselves as well as the world through the lense of Science. Specific topics include things about our brain, emotions to biology, physics and more!

Best Episodes on Science, Humans & The World

The best podcast episodes on romantic relationships. Episodes talk about the 5 love languages, intimacy, and the taboo topics of sexual desires and infidelity. This topic is a deep dive into the science and complexities that face us in our relationships with others. Add episodes you're interested into your queue below!